Patient Product Information &
Professionals Product Information
  • Imatinib Devatis 400 mg Film-coated Tablets (“Patient Information Leaflet)
  • Posaconazol Devatis 40 mg/ml Oral Suspension (“Patient Information Leaflet)*
  • Letrozol Devatis 2,5 mg Film-coated Tablets (“Patient Information Leaflet)
  • Exemestan Devatis 25 mg Film-coated Tablets (“Patient Information Leaflet)
  • Anastrozol Devatis 1 mg Film-coated Tablets (“Patient Information Leaflet)
  • Quetiapin Devatis 25 mg Film-coated Tablets (“Patient Information Leaflet)
  • Quetiapin Devatis 100 mg Film-coated Tablets (“Patient Information Leaflet)
  • Quetiapin Devatis 200 mg Film-coated Tablets (“Patient Information Leaflet)
  • Quetiapin Devatis 300 mg Film-coated Tablets (“Patient Information Leaflet)
  • Amoxicillin/Clavulanic Acid Devatis 250mg/62,5mg Powder for Oral Suspension (“Patient Information Leaflet)
  • Amoxicillin/Clavulanic Acid Devatis 400mg/57mg Powder for Oral Suspension (“Patient Information Leaflet)
  • Diclofenac Devatis 1mg/ml Eyedrops in Single Dose (“Patient Information Leaflet)
  • Ofloxacin Devatis 3 mg/ml Eyedrops in Single Dose (“Patient Information Leaflet)
  • These Devatis Products containing the active substance Imatinib are not approved for the treatment of gastrointestinal stromal tumors and should not be prescribed, sold, recommended or otherwise subject to similar treatment.